Clinical Trial Update: Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of cemiplimab and fianlimab for locally advanced head and neck basal cell carcinoma before surgery, currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Cemiplimab (cemiplimab)
• Fianlimab (fianlimab)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Locally Advanced Basal Cell Carcinoma, Basal Cell Carcinoma | Phase 2 | Status: RECRUITING